Furthermore, high expression level of FASN resulted in a significantly poor prognosis of pancreatic cancer (173), and data from TCGA study suggest that FASN expression could be a marker of bad outcome in cervical and renal cancer (Table 1). Here, FASN is linked to familial pancreatic carcinoma.